We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$14.7B
AUM Growth
+$1.55B
Cap. Flow
-$42.4M
Cap. Flow %
-0.29%
Top 10 Hldgs %
33.58%
Holding
2,110
New
660
Increased
423
Reduced
368
Closed
648

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
COP icon
ConocoPhillips
COP
+$114M
3
AAPL icon
Apple
AAPL
+$80.8M
4
BDX icon
Becton Dickinson
BDX
+$68.3M
5
SHW icon
Sherwin-Williams
SHW
+$62.8M

Sector Composition

Rank Sector Weight
1 Healthcare 10.2%
2 Technology 10.13%
3 Utilities 6.69%
4 Consumer Discretionary 6.52%
5 Industrials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKLO
1451
CALL
Oklo
OKLO
$7.83B
$35K ﹤0.01%
+4,200
New +$47.3K
UA icon
1452
Under Armour Class C
UA
$2.25B
$27K ﹤0.01%
+4,077
New +$27K
MOR
1453
DELISTED
MorphoSys AG American Depositary Shares
MOR
$8K ﹤0.01%
465
-80,663
-99% -$1.47M
HTZ icon
1454
Hertz
HTZ
$802M
$6K ﹤0.01%
+1,782
New +$9.06K
THD icon
1455
iShares MSCI Thailand ETF
THD
$363M
$4K ﹤0.01%
75
XME icon
1456
State Street SPDR S&P Metals & Mining ETF
XME
$4.77B
$1K ﹤0.01%
+18
New +$1.1K
SRCL
1457
DELISTED
Stericycle Inc
SRCL
$1K ﹤0.01%
+18
New +$924
AAL icon
1458
American Airlines Group
AAL
$9.15B
-312,249
Closed -$4.79M
AAON icon
1459
Aaon
AAON
$6.55B
-59,882
Closed -$5.28M
ABCL icon
1460
AbCellera Biologics
ABCL
$3.67B
-496,012
Closed -$2.25M
ABG icon
1461
Asbury Automotive
ABG
$3.86B
-3,616
Closed -$853K
ABM icon
1462
ABM Industries
ABM
$2.74B
-15,237
Closed -$680K
ABOS icon
1463
Acumen Pharmaceuticals
ABOS
$229M
-25,620
Closed -$104K
ACA icon
1464
Arcosa
ACA
$7.12B
-21,179
Closed -$1.82M
ACDC icon
1465
ProFrac Holding
ACDC
$880M
-693,380
Closed -$5.8M
ACCO icon
1466
Acco Brands
ACCO
$391M
-195,040
Closed -$1.09M
ACGL icon
1467
Arch Capital
ACGL
$33.9B
-166,941
Closed -$15.4M
ACVA icon
1468
ACV Auctions
ACVA
$1.26B
-16,807
Closed -$315K
ADC icon
1469
Agree Realty
ADC
$9.19B
-94,622
Closed -$5.41M
ADT icon
1470
ADT
ADT
$5.39B
-414,005
Closed -$2.78M
ADTN icon
1471
Adtran
ADTN
$633M
-45,820
Closed -$249K
ADUS icon
1472
Addus HomeCare
ADUS
$2.26B
-17,582
Closed -$1.82M
AFL icon
1473
Aflac
AFL
$58.2B
-3,897
Closed -$335K
AGEN
1474
Agenus
AGEN
$364M
-1,670
Closed -$19K
AGI icon
1475
Alamos Gold
AGI
$15.8B
-11,109
Closed -$164K

Similar funds

Michael Gelband's Q2 2024 Portfolio in Review

As of Q2 2024, Michael Gelband held 2,110 positions worth $14.7B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband's Q2 2024 filing shows 660 new, 423 increased, 368 reduced and 648 closed positions. Its largest new stake was Coca-Cola: 936,563 shares worth $59.6M. The largest sale was NVIDIA, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.9% a quarter earlier, followed by Technology and Utilities.

  • Michael Gelband's largest Q2 2024 buy was Coca-Cola: 936,563 shares worth $59.6M.
  • Michael Gelband added most to Amazon in Q2 2024, an estimated $231M increase.
  • Michael Gelband's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $351M.
  • Michael Gelband fully exited Global Payments in Q2 2024, selling an estimated $202M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.7B portfolio in Q2 2024.
  • Michael Gelband opened 660 new positions and closed 648 in Q2 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $14.7B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.